AST / ALT Ratio

The AST/ALT ratio compares the levels of two key liver enzymes — aspartate aminotransferase (AST) and alanine aminotransferase (ALT) — to help assess liver health and detect specific types of liver injury. Both enzymes are released into the bloodstream when liver cells are damaged, but their relative proportions can reveal the underlying cause. The ratio is calculated by dividing AST by ALT.

The AST/ALT ratio ratio offers valuable insight into the type and severity of liver disease.

• In most liver conditions such as non-alcoholic fatty liver disease (NAFLD) or viral hepatitis, ALT tends to be higher than AST, giving a ratio less than 1.
  

• A ratio greater than 2 is highly suggestive of alcoholic liver disease, as chronic alcohol consumption damages mitochondria where AST is produced.
  

• A ratio greater than 1 may also signal advanced fibrosis or cirrhosis, when the liver’s ability to regenerate cells declines.
  

• Beyond liver disease, research has linked the AST/ALT ratio to metabolic health, cardiovascular outcomes, and even mortality in critical illness, making it a broad indicator of systemic wellbeing.

The AST/ALT ratio can shift due to both lifestyle and clinical factors:

• Liver Health: Conditions like fatty liver, viral hepatitis, or cirrhosis change enzyme release patterns, directly affecting the ratio.
  

• Alcohol Intake: Chronic alcohol use raises AST levels more than ALT due to mitochondrial injury, increasing the ratio.
  

• Metabolic Dysfunction: Insulin resistance and metabolic syndrome (especially in PCOS) often produce a lower ratio, reflecting hepatic fat accumulation and inflammation.
  

• Medications and Toxins: Certain drugs (like statins, NSAIDs, or acetaminophen) and environmental toxins can damage liver cells, altering enzyme levels.
  

• Muscle Injury: Since AST is also found in muscle, intense exercise or trauma can temporarily raise AST, skewing results.

If the Ratio Is High:
A high AST/ALT ratio often reflects alcohol-related or advanced liver injury, so the focus should be on reducing further damage and supporting liver regeneration.

• Avoid Alcohol and Toxins: Eliminate or limit alcohol and avoid unnecessary medications that stress the liver.
  

• Optimize Nutrition: Eat a Mediterranean-style diet rich in antioxidants, cruciferous vegetables, omega-3 fats, and high-quality protein to reduce inflammation and aid detoxification.
  

• Hydration and Movement: Stay well-hydrated and incorporate moderate physical activity to improve circulation and metabolic function.
  

• Medical Management: If levels remain elevated, testing for viral hepatitis, iron overload, or autoimmune liver disease may be warranted.
  

If the Ratio Is Low:
A low ratio (less than 1) can suggest fatty liver or metabolic dysfunction, particularly when paired with high ALT.

• Balance Blood Sugar: Reduce refined carbohydrates, sugary beverages, and late-night eating to lower hepatic fat accumulation.
  

• Support Weight Management: Achieving a healthy body composition can normalise ALT and improve overall enzyme balance.
  

• Increase Physical Activity: Regular aerobic and resistance exercise helps improve insulin sensitivity and liver enzyme profiles.

• Monitor Over Time: Repeat testing every few months can help track progress and confirm improvements from lifestyle interventions.

1. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. The American Journal of Gastroenterology. 2017;112(1):18–35. doi:10.1038/ajg.2016.517.
   

2. Feng J, Luo R, Cong J, et al. Metabolic Syndrome and Insulin Resistance Are Associated With Normal-Range Aspartate Aminotransferase, Alanine Aminotransferase, and Their Ratio in Chinese Women With Polycystic Ovary Syndrome. Clinical Endocrinology. 2025. doi:10.1111/cen.70018.
   

3. Liu H, Li H, Deng G, et al. Association of AST/ALT Ratio With 90-Day Outcomes in Patients With Acute Exacerbation of Chronic Liver Disease: A Prospective Multicenter Cohort Study in China. Frontiers in Medicine. 2024;11:1307901. doi:10.3389/fmed.2024.1307901.
   

4. Bian Y, Kou H, Jia Z, et al. Association Between Aspartate Aminotransferase to Alanine Aminotransferase Ratio and Mortality in Critically Ill Patients With Congestive Heart Failure.Scientific Reports. 2024;14(1):26317. doi:10.1038/s41598-024-77141-y.